Table 3.

Testing and prophylaxis in MSM overall, non-late presenters (NonLP) and late presenters (LP).

	N	Overall	NonLP (N = 214)	LP (N = 157)	p-value
		N (%) [95% CI] Median (IQR)	N (%) [95% CI] Median (IQR)	N (%) [95% CI] Median (IQR)
Testing and Prophylaxis
HIV testing frequency	356				0.002
More than once per year		161 (45%) [40, 51%]	105 (51%) [44, 58%]	56 (38%) [30, 46%]
Once per year		119 (33%) [29, 39%]	71 (34%) [28, 41%]	48 (32%) [25, 40%]
Never got tested		76 (21%) [17, 26%]	31 (15%) [11, 21%]	45 (30%) [23, 38%]
Pre–exposure prophylaxis (ever)	357				0.6
No		304 (85%) [81, 89%]	180 (87%) [81, 91%]	124 (83%) [76, 89%]
Yes		15 (4.2%) [2.5, 7.0%]	7 (3.4%) [1.5, 7.1%]	8 (5.4%) [2.5, 11%]
Do not know what it is		38 (11%) [7.7, 14%]	21 (10%) [6.5, 15%]	17 (11%) [7, 18%]
Post–exposure prophylaxis (ever)	359				0.5
No		295 (82%) [78, 86%]	175 (84%) [78, 89%]	120 (79%) [72, 85%]
Yes		23 (6.4%) [4.2, 9.6%]	11 (5.3%) [2.8, 9.5%]	12 (7.9%) [4.4, 14%]
Do not know what it is		41 (11%) [8.4, 15%]	22 (11%) [6.9, 16%]	19 (13%) [7.9, 19%]

IQR, Interquartile Range; CI, Confidence Interval.